---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-26-006632"
form_type: "8-K/A"
ticker: "VBIO"
cik: "0001787740"
company_name: "Valion Bio, Inc."
filed_at: "2026-08-20T20:15:14+00:00"
generated_at: "2026-08-20T20:16:18.590004+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Valion Bio stockholders authorize 1-for-5 to 1-for-50 reverse stock split

## Summary
- Special meeting Aug 14, 2026: reverse split proposal approved with 1,243,530 for, 697,127 against, 60,678 abstain.
- Board has 12 months to set split ratio within 1-for-5 to 1-for-50 range without further stockholder approval.
- Quorum was 48.21% (2,001,335 of 4,151,259 outstanding common shares represented).
- Adjornment proposal also passed (1,242,980 for) but not used since Proposal 1 passed.

## SEC filing metadata
- accession: 0001683168-26-006632
- form_type: 8-K/A
- ticker: VBIO
- cik: 0001787740
- company_name: Valion Bio, Inc.
- filed_at: 2026-08-20T20:15:14+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1787740/000168316826006632/0001683168-26-006632-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1787740/000168316826006632/valion_8ka1.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-26-006632
- JSON: https://secwatch.observer/filing/0001683168-26-006632.json
- Plain text: https://secwatch.observer/filing/0001683168-26-006632.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.